|
|
|
Insider
Information: |
Gorman Kevin Charles |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
517,112 |
|
Indirect Shares
|
57,996 |
|
|
Direct
Value |
$71,519,380 |
|
|
Indirect Value
|
$8,086,382 |
|
|
Total
Shares |
575,108 |
|
|
Total
Value |
$79,605,763 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
17.5%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neurocrine Biosciences Inc |
NBIX |
Chief Executive Office... |
2024-02-13 |
512,052 |
2004-09-22 |
57,996 |
Premium* |
|
Xencor Inc |
XNCR |
Director |
2024-02-13 |
5,060 |
2023-06-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NBIX |
Neurocrine Biosciences In... |
Vice President Business Dev. |
|
2004-02-10 |
4 |
S |
$57.29 |
$344,080 |
D/D |
(6,000) |
55,996 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
officerTitle |
|
2005-12-08 |
4 |
S |
$62.74 |
$188,745 |
D/D |
(3,000) |
55,250 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
PRESIDENT AND CEO |
|
2014-12-18 |
4 |
OE |
$2.59 |
$295,150 |
D/D |
70,000 |
195,952 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2015-01-08 |
4 |
OE |
$2.59 |
$64,750 |
D/D |
25,000 |
205,952 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2015-03-24 |
4 |
OE |
$2.59 |
$103,600 |
D/D |
40,000 |
228,452 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2016-12-23 |
4 |
OE |
$2.59 |
$23,569 |
D/D |
9,100 |
237,177 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2017-02-08 |
4 |
OE |
$2.59 |
$166,177 |
D/D |
64,161 |
314,703 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2017-05-02 |
4 |
OE |
$2.59 |
$56,304 |
D/D |
21,739 |
354,346 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2018-02-06 |
4 |
OE |
$5.76 |
$576,000 |
D/D |
100,000 |
442,874 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2018-05-01 |
4 |
OE |
$5.76 |
$730,552 |
D/D |
126,832 |
473,865 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2018-06-28 |
4 |
OE |
$5.76 |
$533,416 |
D/D |
57,924 |
404,957 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2019-08-06 |
4 |
OE |
$8.66 |
$440,889 |
D/D |
50,911 |
468,508 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2019-08-07 |
4 |
OE |
$8.66 |
$23,893 |
D/D |
2,759 |
420,356 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2019-08-08 |
4 |
OE |
$8.66 |
$228,018 |
D/D |
26,330 |
443,927 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2019-08-09 |
4 |
OE |
$32.99 |
$99,993 |
D/D |
3,031 |
420,628 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2021-01-08 |
4 |
OE |
$8.65 |
$2,667,797 |
D/D |
308,250 |
605,872 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2024-01-08 |
4 |
OE |
$19.59 |
$2,073,308 |
D/D |
105,835 |
605,589 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2024-01-09 |
4 |
OE |
$19.59 |
$1,215,031 |
D/D |
62,023 |
561,777 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2024-02-13 |
4 |
OE |
$35.99 |
$199,951 |
D/D |
5,090 |
512,052 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Vice President Business Dev. |
|
2004-09-22 |
4 |
D |
$55.19 |
$100,059 |
I/I |
(1,813) |
57,996 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
|
2018-02-06 |
4 |
D |
$82.48 |
$337,426 |
D/D |
(4,091) |
347,033 |
0 |
- |
|
XNCR |
Xencor Inc |
Director |
|
2024-02-13 |
4 |
B |
$19.12 |
$1,013 |
D/D |
53 |
5,060 |
2.31 |
% |
|
NBIX |
Neurocrine Biosciences In... |
President & CEO |
|
2008-02-12 |
4 |
AS |
$4.96 |
$41,369 |
D/D |
(8,230) |
66,997 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
President & CEO |
|
2009-01-13 |
4 |
AS |
$3.37 |
$31,014 |
D/D |
(9,195) |
82,802 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2009-03-30 |
4 |
AS |
$3.43 |
$51,927 |
D/D |
(15,146) |
109,322 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|